Pande Vijay Satyanand's Form 4 filing
BioAge Labs, Inc. (BIOA) · filed Oct 3, 2024
- Accession no.
- 0001415889-24-024688
- Filed
- Oct 3, 2024
- Trade date
- Oct 1-3, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $4.33M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pande Vijay SatyanandCIK 0001840663 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 1, 2024 | Common Stock | PPurchaseAcquired | +126,793 | $19.73 | +$2,501,625.89 | 1,026,793 | Indirect | |
| Oct 2, 2024 | Common Stock | PPurchaseAcquired | +67,096 | $19.73 | +$1,323,804.08 | 1,093,889 | Indirect | |
| Oct 3, 2024 | Common Stock | PPurchaseAcquired | +25,306 | $19.90 | +$503,589.4 | 1,119,195 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.